GoKawiil
Tech News
Legend Biotech has appointed Ingrid Zhang, an executive from Novartis, as its new chief executive officer. She fills a leadership vacancy that opened in July after the company's previous CEO resigned abruptly.
Novartis and Bristol Myers Squibb have both suspended clinical trials of experimental autoimmune therapies after participants died or suffered life-threatening reactions. The companies are now investigating what caused the treatments, once seen as promising, to turn dangerous.
Novartis suspended eight clinical trials testing a cell therapy for autoimmune and neurological conditions after three participants died in late August. The company has not disclosed the cause of death or which specific therapy is affected beyond confirming the pause across all related studies.